News & Updates
Filter by Specialty:

Benralizumab helps maintain severe asthma control with reduced ICS doses
22 Sep 2023
byJairia Dela Cruz
Treatment with benralizumab allows tapering of inhaled corticosteroid (ICS) doses for patients with severe eosinophilic asthma, without compromising disease control and increasing exacerbations, as shown in the results of the phase IV SHAMAL study.